Literature DB >> 20097265

The differential effects of equipotent doses of isoflurane and desflurane on hippocampal acetylcholine levels in young and aged rats.

Robert A Whittington1, László Virág.   

Abstract

The differential effects of age-adjusted equipotent doses of isoflurane (Iso) and desflurane (Des) on hippocampal acetylcholine (ACh) levels were examined using cerebral microdialysis in young (12-16 weeks old) and aged (16-18 months old) Fischer 344 rats. An 80min exposure to 1 minimum alveolar concentration (MAC) of isoflurane and desflurane produced similar maximal decreases in hippocampal ACh levels in both age groups: to 36.3+/-13.9% (Iso) and 28.6+/-12.9% (Des) of baseline in aged rats versus 32.5+/-18.7% (Iso) and 29.6+/-12.5% (Des) of baseline in young rats. Compared to isoflurane, the onset of this maximal decrease was delayed in both age groups with desflurane. Furthermore, following the end of anesthesia in aged rats, hippocampal ACh levels returned to control levels faster with desflurane (within 20-40min) than isoflurane (within 60-80min). These data demonstrate that age-adjusted equipotent doses of isoflurane and desflurane produce similar maximal decreases in hippocampal ACh levels in a manner that is independent of age. However, compared to isoflurane, desflurane is associated with a slower decrease in and a faster restoration of hippocampal ACh levels following anesthesia in this rat model of aging. Hence, in the aged, the administration of age-adjusted equipotent doses of an inhalational anesthetic with low blood and tissue solubility, such as desflurane, may provide a viable pharmacotherapeutic strategy for minimizing the duration of the attenuation of hippocampal cholinergic outflow observed following anesthesia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097265     DOI: 10.1016/j.neulet.2010.01.034

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Pancuronium enhances isoflurane anesthesia in rats via inhibition of cerebral nicotinic acetylcholine receptors.

Authors:  Yusuke Miyazaki; Hiroshi Sunaga; Shotaro Hobo; Kazuko Miyano; Shoichi Uezono
Journal:  J Anesth       Date:  2016-05-04       Impact factor: 2.078

2.  Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice.

Authors:  Yuta Madokoro; Yuta Yoshino; Daisuke Kato; Toyohiro Sato; Masayuki Mizuno; Tetsuko Kanamori; Masamitsu Shimazawa; Hideki Hida; Hideaki Hara; Mari Yoshida; Cesario V Borlongan; Kosei Ojika; Noriyuki Matsukawa
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.